137 related articles for article (PubMed ID: 9814553)
1. Ganglioside changes in brain in chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat.
Zaprianova E; Deleva D; Filchev A
Neurochem Res; 1998 Nov; 23(11):1421-5. PubMed ID: 9814553
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside spinal cord changes in chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rats.
Zaprianova E; Deleva D; Hauttecoeur B; Bakalska M; Filchev A
Neurochem Res; 1997 Feb; 22(2):175-9. PubMed ID: 9016843
[TBL] [Abstract][Full Text] [Related]
3. [Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis].
Zaprianova E; Deleva D; Bakalska M; Filchev N
Morfologiia; 1997; 112(6):25-8. PubMed ID: 9606089
[TBL] [Abstract][Full Text] [Related]
4. The neuropathology of chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat by inoculation with whole spinal cord and treatment with cyclosporin A.
Pender MP; Stanley GP; Yoong G; Nguyen KB
Acta Neuropathol; 1990; 80(2):172-83. PubMed ID: 2389682
[TBL] [Abstract][Full Text] [Related]
5. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
[TBL] [Abstract][Full Text] [Related]
6. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
[TBL] [Abstract][Full Text] [Related]
7. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
Panitch H; Ciccone C
Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.
Yao DL; Liu X; Hudson LD; Webster HD
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6190-4. PubMed ID: 7541143
[TBL] [Abstract][Full Text] [Related]
10. Lipid changes in central nervous system membranes in experimental allergic encephalomyelitis (EAE).
Salvati S; Attorri L; Confaloni A; Di Biase A
Neurochem Res; 1990 Nov; 15(11):1051-3. PubMed ID: 2089265
[TBL] [Abstract][Full Text] [Related]
11. Selective lipid alterations during experimental allergic encephalomyelitis -- an interpretation of the changes.
Cumar FA; Maggio B; Roth GA
Adv Exp Med Biol; 1977; 83():505-11. PubMed ID: 920478
[No Abstract] [Full Text] [Related]
12. Niridazole suppression of experimental allergic encephalomyelitis in Lewis rats.
Paterson PY; Harvey JM; Webster LT
J Immunol; 1977 Jun; 118(6):2151-4. PubMed ID: 301156
[TBL] [Abstract][Full Text] [Related]
13. Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats.
Núñez MJ; Balboa J; Rey-Méndez M; Brenlla J; González-Peteiro M; Rodrigo E; Freire-Garabal M
Hum Exp Toxicol; 2007 Aug; 26(8):637-43. PubMed ID: 17884951
[TBL] [Abstract][Full Text] [Related]
14. Influence of gangliosides on experimental allergic neuritis.
Wiethölter H; Schabet M; Stevens A; Melms A; Sommer N; Weller M
J Neuroimmunol; 1992 Jun; 38(3):221-8. PubMed ID: 1601979
[TBL] [Abstract][Full Text] [Related]
15. Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis.
Raine CS; Traugott U
Ann N Y Acad Sci; 1984; 436():33-51. PubMed ID: 6085228
[No Abstract] [Full Text] [Related]
16. Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.
Kovarik J; Chabannes D; Borel JF
Int J Immunopharmacol; 1995 Apr; 17(4):255-63. PubMed ID: 7545648
[TBL] [Abstract][Full Text] [Related]
17. Influence of cerebroside and ganglioside on the encephalitogenic activity of myelin basic protein in guinea pigs.
Brinkman CJ; ter Laak HJ; Hommes OR
Acta Neurol Scand; 1983 Mar; 67(3):143-50. PubMed ID: 6191512
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats.
Wiegmann K; Muthyala S; Kim DH; Arnason BG; Chelmicka-Schorr E
J Neuroimmunol; 1995 Feb; 56(2):201-6. PubMed ID: 7860715
[TBL] [Abstract][Full Text] [Related]
19. Gangliosides offer partial protection in experimental allergic neuritis.
Ledeen RW; Oderfeld-Nowak B; Brosnan CF; Cervone A
Ann Neurol; 1990; 27 Suppl():S69-74. PubMed ID: 2363571
[TBL] [Abstract][Full Text] [Related]
20. The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs.
Keith AB; Arnon R; Teitelbaum D; Caspary EA; Wisniewski HM
J Neurol Sci; 1979 Jul; 42(2):267-74. PubMed ID: 90129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
